Jonathan E Freeman
Director at Phio Pharmaceuticals Corp. (PHIO)
Jonathan E Freeman has filed 6 insider reports with the SEC since March 2021, as director at Phio Pharmaceuticals Corp. (PHIO). The latest filing, on February 6, 2026, reports grant or award at Phio Pharmaceuticals Corp. (PHIO).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Jonathan E Freeman is an insider
| Company | Role | Shares held | Bought | Sold | Last filing |
|---|---|---|---|---|---|
| PHIO Phio Pharmaceuticals Corp. | Director | 32,655 | Feb 6, 2026 |
Shares held: common shares owned directly after the latest filing that states it.
Every filing
- Feb 5, 2026PHIODirector Freeman Jonathan E was granted 16,600 shares, increasing direct ownership by 103% to 32,655 unitsForm 4Grant or award
- Sep 11, 2025PHIODirector Freeman Jonathan E was granted 14,700 shares, increasing direct ownership by 1,085% to 16,055 unitsForm 4Grant or award
- Sep 11, 2024PHIODirector Freeman Jonathan E was granted 1,000 sharesForm 4Grant or award
- Feb 17, 2023PHIOSEC Form 4: Freeman Jonathan E was granted 1,500 shares, increasing direct ownership by 88% to 3,197 unitsForm 4Grant or award
- Feb 15, 2022PHIOSEC Form 4: Freeman Jonathan E was granted 10,000 shares, increasing direct ownership by 96% to 20,364 unitsForm 4Grant or award
- Mar 1, 2021PHIOSEC Form 4: E Jonathan Freeman was granted 10,000 units of Common stock, increasing ownership by 2,747% to 10,364 unitsForm 4Grant or award
Other insiders at the same companies
- Ronald Todd PlottPHIO
- Robert J BittermanPHIO
- Lisa Cabott CarsonPHIO
- Patricia A BradfordPHIO
- Curtis LockshinPHIO
- David H DemingPHIO
- Robert L FerraraPHIO
Questions about Jonathan E Freeman
- What is Jonathan E Freeman's role at Phio Pharmaceuticals Corp.?
- Jonathan E Freeman reports to the SEC as director at Phio Pharmaceuticals Corp. (PHIO), according to the latest filing on February 6, 2026.
- How many shares does Jonathan E Freeman own?
- After the latest filing that states it, Jonathan E Freeman directly owned 32,655 shares of Phio Pharmaceuticals Corp. (PHIO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jonathan E Freeman bought or sold stock recently?
- No open-market purchases or sales by Jonathan E Freeman are on file. The filings report grant or award.
- How do I get alerts when Jonathan E Freeman files?
- Follow Jonathan E Freeman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5.
From SEC Forms 4 and 5 filed by Jonathan E Freeman (SEC CIK 0001708133). Totals count each trade once, skipping amendments whose original is on file, from Mar 4, 2021 on. View on SEC EDGAR